Dr. Ashok Vaid Medical Oncologist in Gurgaon

Dr. Ashok Vaid

Medical Oncologist, Gurgaon


  • 1 Hospital


  • Senior Residency towards award of MD degree   in Internal Medicine,Govt.Medical College,Jammu,Jammu&Kashmir,India1987-1989
  • Senior Resident, Dept. of Clinical Immunology, SGPGI, Lucknow, UP, India Jan - Apr 1990
  • Senior Resident, Dept. of Medical Oncology, All India Institute of Medical Science (AIIMS), New Delhi, India,1990-1991
  • Post MD Training Towards Award of DM Degree, Medical Oncology,Cancer Institute, Adyar, Chennai, India,1991-1993
  • Consultant -Medical Oncologist & Lecturer Dept. of Internal Medicine
  • Govt. Medical College, Jammu, J&K, India, 1994-1997
  • Sr. Consultant & Coordinator, Dept. of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India, 1997-2007
  • Head, Dept. of Medical Oncology, Artemis Health Institute, Gurgaon, India, 2007 - 2009
  • Chairman - Division of Medical & Paediatric Oncology, Haematology &
  • Bone Marrow / Stem Cell Transplant Medanta – The Medicity, Gurgaon, 2009 – till date


  • Medical Oncology


  • Stem Cell Transplant


  • Cancer

  • Leukemia

  • Lymphoma


  • Treatment of organ specific cancers
  • Leukemias
  • Lymphomas
  • Stem Cell Transplantation


  • D.M, Medical Oncology from Dr. MGR Medical University, Chennai,1993
  • M.D, Internal Medicine from University of Jammu, J&K, India,1989
  • M.B.B.S from University of Jammu, J&K, India,1983
  • Senior Resident  from Dept. of Medical Oncology at IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India,1990

Practice Information

Medanta - The Medicity, Gurgaon

Medanta - The Medicity, Gurgaon

Sector 38, Gurgaon, Haryana - 122001

Achievements & Contributions

  • Padma Shree award by the President of India for contribution to the field of medicin, 14th April, 2009
  • Dr. Ashok Vaid has authored a number of publications, research papers and abstracts and has been actively involved in organizing various seminars, workshops and conferences throughout the country
  • Management of Malignant Germ Cell Tumours of Ovary,Indian J Cancer. 1992 Sep;29 (3) :122-5
  • Synchronous oesophageal carcinoma with non Hodgkin's lymphoma, problems with management Indian J Cancer. 1996 Sep;33 (3) :153-6
  • Prognostic factors in early stage Non-Small Lung Carcinoma, Ind J Med & Ped Oncol 20:56-85
  • Environmental Pollution and Lung Cancer. In: Clearing the Air Better Vehicles, Better Fuels Published by Teri, Delhi. Pg 19-23, 2000
  • Small cell carcinoma of the gall bladder: case report and review of literature, Tropical Gastroenterol. Jul-Sep;22(3):170-1
  • Spontaneous fracture and pulmonary embolization of a central venous catheter, The Journal of Vascular Access. 4:158-159
  • Flagellate hyperpigmentation from bleomycin, Indian J Dermatol Venerol Leprol 70:46-47
  • Hodgkin’s Disease: Risk Stratification and Multidisciplinary Treatment, JK Science (Journal of Medical Education & Research) Vol.7 No.2, April-June 2005: p63-66. (Review Article)
  • Bone metastases from primary hepatocellular carcinoma simulating multiple myeloma, Hepatobiliary Pancreat Dis. Int. Vol.4,No.2, May 15,2005:308-10
  • Gastric carcinoma presenting as cutaneous metastases, Indian J Dermatol Venereol Leprol. 2005 May-Jun;71(3):208-9
  • Primary Testicular Lymphoma: A Case Report, Haema 2006; 9(2):286-289
  • Breast carcinoma with metastasis to the gallbladder: an unusual case report with a short review of literature, Hepatobiliary Pancreat Dis Int. 2006 May; 5(2):305-7. Review. PMID:16698597
  • Significant Impact of a Single Gallium (Ga67) Scintigraphy in the Management of Lymphomas,HICC World Cancer Congress, Medimond International Proceedings, Washington, D.C. (USA), July 8-12, 2006.
  • Oral Talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase-2 trial: C1-05, Journal of Thoracic Oncology, August 2007 - Volume 2 - Issue 8 - p S360
  • Haematologic Paraneoplastic Syndromes in Pleural Mesothelioma: A Report of Two Cases and Review of the Literature, The Indian Journal of Chest Diseases & Allied Sciences, 2009;Vol.51
  • Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study, J Clin Oncol. 2009 Nov 20;27(33):5529-37. Epub 2009 Sep 28
  • Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from India, Indian J Cancer. 2011 Apr-Jun;48(2):158-64
  • Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy, J Clin Oncol. 2011 Nov 1;29(31): 4129-36. Epub 2011 Oct 3
  • Book Chapter:  
  • Recent Advances in Drug Therapy of Multiple Myeloma. Ashok K Vaid, Komal Bhatia. Clinical medicine: A practical manual for students and practitioners. A publication of Indian association of clinical medicine.  Page; 343-348: Chapter 37. Jaypee Brothers Publication. January 2007.
  • Talwar V, Vaid AK, Doval DC, Bhatia K, Jena A, Anand AK. Isolated intraorbital metastasis in carcinoma breast. Jour of Association of Physicians of India 2007June; Vol55:451-452. PMID: 17879503
  • Indian Society of Medical & Pediatric Oncology (ISMPO)
  • Founder, Member of Indian Cooperative Oncology Network (ICON)
  • Breast Cancer Foundation of India – Life Member
  • Indian Association of Gynaec Oncologists (IAGO) – Life Member
  • Indian Medical Association (IMA) – Life Member
  • Association of Physicians of India (API)
  • Indian Association of Clinical Medicine (IACM) – Life Member
  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology (ESMO)
  • European Hematology Association (EHA)
  • Member Editorial Board - Current Trends in Asian Oncology
  • Consultant Editor JK Science (Journal of Medical Education & Research) Jammu J&K (India)

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Ashok Vaid and his staff know how they are doing and how they can improve their services.